|
|
Previous Article | Table of Contents | Next Article 
Changes in cell surface antigen expressions during proliferation and
differentiation of human erythroid progenitors
N Okumura, K Tsuji and T Nakahata
Central Clinical Laboratories, Shinshu University Hospital, Matsumoto,
Japan.
Cell surface antigen expression during proliferation and differentiation of
human erythroid progenitors was examined using a combination of sequential
micromanipulations of paired daughter cells derived from erythroid
burst-forming units (BFU-E) and immuno-staining with a panel of monoclonal
antibodies. Single hematopoietic progenitors were identified in
methylcellulose cultures containing human cord blood mononuclear cells and
micromanipulated individually to secondary culture. Paired daughter cells,
granddaughter cells, and subsequent generations, whose counterparts
produced erythroid bursts, were stained with various cytochemical and
immuno-alkaline phosphatase stainings. Most paired daughter cells of BFU-E
immunostained positively with anti- platelet glycoprotein(GP) IIb,
antiplatelet GPIIb/IIIa, anti-HLA-DR, and antitransferrin receptor
antibodies. Acid phosphatase staining was also positive. Neither CD34 nor
CD33 antigens were identified on the cells. CD36 and blood group A antigens
were first identified on cells from aggregates containing 32 to 64 cells
after 4 days of secondary culture and preceded the expression of
glycophorin A and hemoglobin alpha. These results indicate that various
cell surface antigens were sequentially expressed during the proliferation
and differentiation of erythroid progenitors, and that our procedure may be
useful for clarifying the morphologic and immunologic properties of
hematopoietic stem cells.
Volume 80,
Issue 3,
pp. 642-650,
08/01/1992
Copyright © 1992 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. A. Dalmas, L. A. Tierney, C. Zhang, P. K. Narayanan, R. W. Boyce, L. W. Schwartz, K. S. Frazier, and M. S. Scicchitano
Effects of p38 MAP Kinase Inhibitors on the Differentiation and Maturation of Erythroid Progenitors
Toxicol Pathol,
December 1, 2008;
36(7):
958 - 971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Wong, N. Zhi, C. Filippone, K. Keyvanfar, S. Kajigaya, K. E. Brown, and N. S. Young
Ex Vivo-Generated CD36+ Erythroid Progenitors Are Highly Permissive to Human Parvovirus B19 Replication
J. Virol.,
March 1, 2008;
82(5):
2470 - 2476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Grundemann, S. Harlfinger, S. Golz, A. Geerts, A. Lazar, R. Berkels, N. Jung, A. Rubbert, and E. Schomig
Discovery of the ergothioneine transporter
PNAS,
April 5, 2005;
102(14):
5256 - 5261.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ohene-Abuakwa, K. A. Orfali, C. Marius, and S. E. Ball
Two-phase culture in Diamond Blackfan anemia: localization of erythroid defect
Blood,
January 15, 2005;
105(2):
838 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tonks, L. Pearn, A. J. Tonks, L. Pearce, T. Hoy, S. Phillips, J. Fisher, J. R. Downing, A. K. Burnett, and R. L. Darley
The AML1-ETO fusion gene promotes extensive self-renewal of human primary erythroid cells
Blood,
January 15, 2003;
101(2):
624 - 632.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Harashima, M. Suzuki, A. Okochi, M. Yamamoto, Y. Matsuo, R. Motoda, T. Yoshioka, and K. Orita
CD45 tyrosine phosphatase inhibits erythroid differentiation of umbilical cord blood CD34+ cells associated with selective inactivation of Lyn
Blood,
December 15, 2002;
100(13):
4440 - 4445.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Lee, P. Gane, F. Roudot-Thoraval, B. Godeau, D. Bachir, F. Bernaudin, J.-P. Cartron, F. Galacteros, and P. Bierling
The nonexpression of CD36 on reticulocytes and mature red blood cells does not modify the clinical course of patients with sickle cell anemia
Blood,
August 15, 2001;
98(4):
966 - 971.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Ma, M. Wada, H. Yoshino, Y. Ebihara, T. Ishii, A. Manabe, R. Tanaka, T. Maekawa, M. Ito, H. Mugishima, et al.
Development of human lymphohematopoietic stem and progenitor cells defined by expression of CD34 and CD81
Blood,
June 15, 2001;
97(12):
3755 - 3762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Vannucchi, L. Bianchi, C. Cellai, F. Paoletti, V. Carrai, A. Calzolari, L. Centurione, R. Lorenzini, C. Carta, E. Alfani, et al.
Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1low mice)
Blood,
May 15, 2001;
97(10):
3040 - 3050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Debili, C. Robin, V. Schiavon, R. Letestu, F. Pflumio, M.-T. Mitjavila-Garcia, L. Coulombel, and W. Vainchenker
Different expression of CD41 on human lymphoid and myeloid progenitors from adults and neonates
Blood,
April 1, 2001;
97(7):
2023 - 2030.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Lepage, M. Leboeuf, J.-P. Cazenave, C. de la Salle, F. Lanza, and G. Uzan
The alpha IIbbeta 3 integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34+ cord blood cells to megakaryocytes
Blood,
December 15, 2000;
96(13):
4169 - 4177.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Vannucchi, F. Paoletti, S. Linari, C. Cellai, R. Caporale, P. R. Ferrini, M. Sanchez, G. Migliaccio, and A. R. Migliaccio
Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice
Blood,
April 15, 2000;
95(8):
2559 - 2568.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. J.G. Southcott, M. J.A. Tanner, and D. J. Anstee
The Expression of Human Blood Group Antigens During Erythropoiesis in a Cell Culture System
Blood,
June 15, 1999;
93(12):
4425 - 4435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Sui, K. Tsuji, Y. Ebihara, R. Tanaka, K. Muraoka, M. Yoshida, K. Yamada, K. Yasukawa, T. Taga, T. Kishimoto, et al.
Soluble Interleukin-6 (IL-6) Receptor With IL-6 Stimulates Megakaryopoiesis From Human CD34+ Cells Through Glycoprotein (gp)130 Signaling
Blood,
April 15, 1999;
93(8):
2525 - 2532.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Iguchi, S. Sogo, H. Hisha, S. Taketani, Y. Adachi, R. Miyazaki, H. Ogata, S. Masuda, R. Sasaki, M. Ito, et al.
HGF Activates Signal Transduction from EPO Receptor on Human Cord Blood CD34+/CD45+ Cells
Stem Cells,
March 1, 1999;
17(2):
82 - 91.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. S. Pereira, C. Dorrell, C. Y. Ito, O. I. Gan, B. Murdoch, V. N. Rao, J.-P. Zou, E. S. P. Reddy, and J. E. Dick
Retroviral transduction of TLS-ERG initiates a leukemogenic program in normal human hematopoietic cells
PNAS,
July 7, 1998;
95(14):
8239 - 8244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Sato, S. Watanabe, E. Ishii, K. Tsuji, and T. Nakahata
Induction of the Erythropoietin Receptor Gene and Acquisition of Responsiveness to Erythropoietin by Stem Cell Factor in HML/SE, a Human Leukemic Cell Line
J. Biol. Chem.,
July 3, 1998;
273(27):
16921 - 16926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Ebihara, K. Tsuji, S. D. Lyman, X. Sui, M. Yoshida, K. Muraoka, K. Yamada, R. Tanaka, and T. Nakahata
Synergistic Action of Flt3 and gp130 Signalings in Human Hematopoiesis
Blood,
December 1, 1997;
90(11):
4363 - 4368.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. W. Knowles, L. Tilley, N. Mohandas, and J. A. Chasis
Erythrocyte membrane vesiculation: Model for the molecular mechanism of protein sorting
PNAS,
November 25, 1997;
94(24):
12969 - 12974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Tropel, V. Roullot, M. Vernet, C. Poujol, H. Pointu, P. Nurden, G. Marguerie, and D. Tronik-Le Roux
A 2.7-kb Portion of the 5' Flanking Region of the Murine Glycoprotein alpha IIb Gene Is Transcriptionally Active in Primitive Hematopoietic Progenitor Cells
Blood,
October 15, 1997;
90(8):
2995 - 3004.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sakatoku and S. Inoue
In Vitro Proliferation and Differentiation of Erythroid Progenitors of Cord Blood
Stem Cells,
July 1, 1997;
15(4):
268 - 274.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. L. Darley, T. G. Hoy, P. Baines, R. A. Padua, and A. K. Burnett
Mutant N-RAS Induces Erythroid Lineage Dysplasia in Human CD34+ Cells
J. Exp. Med.,
April 7, 1997;
185(7):
1337 - 1348.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Styles, B. Lubin, E. Vichinsky, S. Lawrence, M. Hua, S. Test, and F. Kuypers
Decrease of Very Late Activation Antigen-4 and CD36 on Reticulocytes in Sickle Cell Patients Treated With Hydroxyurea
Blood,
April 1, 1997;
89(7):
2554 - 2559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E Barbe, I Huitinga, E. Dopp, J Bauer, and C. Dijkstra
A novel bone marrow frozen section assay for studying hematopoietic interactions in situ: the role of stromal bone marrow macrophages in erythroblast binding
J. Cell Sci.,
January 12, 1996;
109(12):
2937 - 2945.
[Abstract]
[PDF]
|
 |
|
|
|